Human coronavirus NL63 is not detected in the respiratory tracts of children with acute Kawasaki disease.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMC 2888540)

Published in J Infect Dis on October 17, 2005

Authors

Chisato Shimizu1, Hiroko Shike, Susan C Baker, Francesca Garcia, Lia van der Hoek, Taco W Kuijpers, Sharon L Reed, Anne H Rowley, Stanford T Shulman, Helen K B Talbot, John V Williams, Jane C Burns

Author Affiliations

1: Department of Pediatrics, University of California, San Diego, School of Medicine, La Jolla, 92093, USA.

Articles cited by this

Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation (2004) 11.41

Identification of a new human coronavirus. Nat Med (2004) 11.24

A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics (1974) 9.97

A previously undescribed coronavirus associated with respiratory disease in humans. Proc Natl Acad Sci U S A (2004) 5.76

Association between a novel human coronavirus and Kawasaki disease. J Infect Dis (2005) 3.71

Evidence of a novel human coronavirus that is associated with respiratory tract disease in infants and young children. J Infect Dis (2005) 2.60

Coronavirus infection in acute lower respiratory tract disease of infants. J Infect Dis (1974) 2.55

A novel pancoronavirus RT-PCR assay: frequent detection of human coronavirus NL63 in children hospitalized with respiratory tract infections in Belgium. BMC Infect Dis (2005) 2.28

Human coronavirus NL63 infection in Canada. J Infect Dis (2005) 1.93

Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr (1998) 1.84

Seasonality and temporal clustering of Kawasaki syndrome. Epidemiology (2005) 1.59

Kawasaki syndrome: description of two outbreaks in the United States. N Engl J Med (1981) 1.52

Laboratory diagnosis of SARS. Emerg Infect Dis (2004) 1.41

Detection of antigen in bronchial epithelium and macrophages in acute Kawasaki disease by use of synthetic antibody. J Infect Dis (2004) 1.31

An epidemic of Kawasaki syndrome in Hawaii. J Pediatr (1982) 1.19

Analysis of mRNA from microdissected frozen tissue sections without RNA isolation. Am J Pathol (1998) 1.05

Changes in epidemic patterns of Kawasaki disease in Japan. Pediatr Infect Dis J (1999) 0.99

Lack of association between Kawasaki syndrome and infection with parvovirus B19, human herpesvirus 8, TT virus, GB virus C/hepatitis G virus or Chlamydia pneumoniae. Pediatr Infect Dis J (2000) 0.98

Adenovirus, adeno-associated virus and Kawasaki disease. Pediatr Infect Dis J (2005) 0.95

[Infectious disease theory of Kawasaki disease (muco-cutaneous lymph node syndrome)-with special reference to the theory of virus infection as a triggering factor]. Nihon Rinsho (1976) 0.93

Kawasaki syndrome in two cousins with parainfluenza virus infection. Am J Dis Child (1982) 0.81

Articles by these authors

Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation (2007) 11.64

Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation (2004) 11.41

Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation (2005) 10.98

Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics (2004) 8.10

Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol (2013) 4.98

Real-time reverse transcription-PCR assay for comprehensive detection of human rhinoviruses. J Clin Microbiol (2007) 3.95

RNA replication of mouse hepatitis virus takes place at double-membrane vesicles. J Virol (2002) 3.69

Chronic granulomatous disease: the European experience. PLoS One (2009) 3.04

Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis (2012) 2.91

Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. Nat Immunol (2011) 2.85

ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet (2007) 2.77

Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation (2009) 2.64

Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. Nat Med (2010) 2.59

A novel group of rhinoviruses is associated with asthma hospitalizations. J Allergy Clin Immunol (2008) 2.53

The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity. J Virol (2005) 2.49

Density interactions among Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus in the nasopharynx of young Peruvian children. Pediatr Infect Dis J (2013) 2.47

A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease. PLoS Genet (2009) 2.45

Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr (2008) 2.44

A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target. Nat Med (2012) 2.39

Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease. Nat Genet (2010) 2.32

Baylisascariasis. Clin Microbiol Rev (2005) 2.29

A novel pancoronavirus RT-PCR assay: frequent detection of human coronavirus NL63 in children hospitalized with respiratory tract infections in Belgium. BMC Infect Dis (2005) 2.28

Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme. Proc Natl Acad Sci U S A (2006) 2.28

Influence of maternal asthma on the cause and severity of infant acute respiratory tract infections. J Allergy Clin Immunol (2012) 2.26

Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc Natl Acad Sci U S A (2005) 2.21

Infliximab treatment for refractory Kawasaki syndrome. J Pediatr (2005) 2.21

Nonvalvular cardiovascular device-related infections. Circulation (2003) 2.19

Integrating abundance and functional traits reveals new global hotspots of fish diversity. Nature (2013) 2.13

Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus. J Biol Chem (2007) 2.07

Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults. J Infect Dis (2008) 2.02

Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D. Science (2013) 2.00

Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. J Am Dent Assoc (2007) 1.98

The Great Migration of 2015. Pediatr Ann (2015) 1.98

Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat Genet (2011) 1.97

Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity. J Virol (2004) 1.97

Detection of new viruses by VIDISCA. Virus discovery based on cDNA-amplified fragment length polymorphism. Methods Mol Biol (2008) 1.95

Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. Circulation (2015) 1.95

Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities. PLoS One (2011) 1.94

Human coronavirus in young children hospitalized for acute respiratory illness and asymptomatic controls. Pediatr Infect Dis J (2012) 1.93

Human rhinovirus species associated with hospitalizations for acute respiratory illness in young US children. J Infect Dis (2011) 1.93

CD47-signal regulatory protein-α (SIRPα) interactions form a barrier for antibody-mediated tumor cell destruction. Proc Natl Acad Sci U S A (2011) 1.91

When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood. J Am Coll Cardiol (2009) 1.88

Human bocavirus can be cultured in differentiated human airway epithelial cells. J Virol (2009) 1.85

Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. J Infect Dis (2012) 1.84

Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age. Pediatrics (2013) 1.83

Prevalence of Kawasaki disease in young adults with suspected myocardial ischemia. Circulation (2012) 1.82

The long noncoding RNA THRIL regulates TNFα expression through its interaction with hnRNPL. Proc Natl Acad Sci U S A (2013) 1.78

Failure of routine diagnostic methods to detect influenza in hospitalized older adults. Infect Control Hosp Epidemiol (2010) 1.77

Performance of a rapid antigen-detection test and throat culture in community pediatric offices: implications for management of pharyngitis. Pediatrics (2009) 1.76

Human metapneumovirus infection in children hospitalized for wheezing. J Allergy Clin Immunol (2005) 1.75

Human NK cells can control CMV infection in the absence of T cells. Blood (2008) 1.75

Advances in Kawasaki disease. Eur J Pediatr (2004) 1.66

Burden of human metapneumovirus infection in young children. N Engl J Med (2013) 1.65

Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases. J Virol (2010) 1.64

A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction. J Virol (2009) 1.63

Comparison of the MChip to viral culture, reverse transcription-PCR, and the QuickVue influenza A+B test for rapid diagnosis of influenza. J Clin Microbiol (2007) 1.63

Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B. Hum Mutat (2009) 1.62

Unique features of infective endocarditis in childhood. Circulation (2002) 1.61

Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c mice. J Virol (2011) 1.61

Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura. Blood (2007) 1.60

Seasonality and temporal clustering of Kawasaki syndrome. Epidemiology (2005) 1.59

Human NLRP3 inflammasome activation is Nox1-4 independent. Blood (2010) 1.59

The novel human coronaviruses NL63 and HKU1. J Virol (2006) 1.59

A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet (2012) 1.58

Identification of sequential viral escape mutants associated with altered T-cell responses in a human immunodeficiency virus type 1-infected individual. J Virol (2003) 1.57

Infiltrated neutrophils acquire novel chemokine receptor expression and chemokine responsiveness in chronic inflammatory lung diseases. J Immunol (2008) 1.56

Searching for the cause of Kawasaki disease--cytoplasmic inclusion bodies provide new insight. Nat Rev Microbiol (2008) 1.56

Point-of-care differentiation of Kawasaki disease from other febrile illnesses. J Pediatr (2012) 1.55

Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults. J Infect Dis (2011) 1.54

Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies. Biol Blood Marrow Transplant (2005) 1.54

Fulminant mulch pneumonitis: an emergency presentation of chronic granulomatous disease. Clin Infect Dis (2007) 1.52

Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency. Blood (2013) 1.51

Low plasma D-dimer concentration predicts the absence of traumatic brain injury in children. J Trauma (2010) 1.50

Dynamic epidemiology of group A streptococcal serotypes. Lancet (2002) 1.50

Disparities between black and white children in hospitalizations associated with acute respiratory illness and laboratory-confirmed influenza and respiratory syncytial virus in 3 US counties--2002-2009. Am J Epidemiol (2013) 1.50

Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease. J Infect Dis (2005) 1.49

Transmission networks of HIV-1 among men having sex with men in the Netherlands. AIDS (2010) 1.49

Identification of the murine coronavirus MP1 cleavage site recognized by papain-like proteinase 2. J Virol (2003) 1.47

Impressions of Kawasaki syndrome in India. Indian Pediatr (2006) 1.47

Isolation and characterization of current human coronavirus strains in primary human epithelial cell cultures reveal differences in target cell tropism. J Virol (2013) 1.47

Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species. Proc Natl Acad Sci U S A (2010) 1.47

Increased attack rate of meningococcal disease in children with a pregnant mother. Pediatrics (2005) 1.46

Transforming growth factor-beta signaling pathway in patients with Kawasaki disease. Circ Cardiovasc Genet (2010) 1.45

Even skeptics must be aware of data on alternative therapies. Pediatr Ann (2004) 1.45

Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study. PLoS One (2012) 1.45